EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity

Yuefan Bai iD, Hongming Huang, Xudong Hang, Shanwei Hu, Qian Tong, Jingchen Xu iD, Jia Jia, Hongkai Bi iD

Advanced Science · 2026

DOI: 10.1002/advs.76080 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuefan Bai und 7 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Tropical Disease Control, School of Life Sciences and Medical Technology, Hainan Medical University, Haikou, Hainan, China. Hauptthemen laut MEDLINE: Abietanes, Helicobacter pylori, Helicobacter Infections, Anti-Bacterial Agents. Die Arbeit nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation, China Postdoctoral Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Helicobacter pylori ( H. pylori ) is a significant global human pathogen intricately linked to gastritis, peptic ulcers, and gastric cancer. The escalating challenge of antimicrobial resistance and the adverse effects of conventional antibiotics on the gut microbiome necessitate the development of novel, targeted therapeutics. In this study, we demonstrate that carnosic acid (CA), a natural compound derived from traditional Chinese medicine, exhibits potent and specific anti‐ H. pylori activity in vitro, with no detectable resistance observed after prolonged serial passaging. CA also displayed enhanced antibacterial efficacy under physiologically relevant acidic conditions, correlating with its strong inhibition of urease, a key colonization factor for H. pylori . Beyond urease suppression, CA acted through multiple mechanisms, including inhibiting biofilm formation and disrupting mature biofilms, impairing bacterial motility, and compromising cell membrane integrity. In vivo, the combination of CA and omeprazole achieved superior eradication in a mouse model of multidrug‐resistant H. pylori infection compared to standard triple therapy. Furthermore, CA treatment showed negligible toxicity to host tissues and minimal disruption to the diversity and composition of the gut microbiota. These findings position CA as a promising lead compound against drug‐resistant H. pylori , offering a multi‐targeting and microbiota‐friendly strategy to combat this pathogen.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AbietanesHelicobacter pyloriHelicobacter InfectionsAnti-Bacterial AgentsDrug Resistance, Multiple, BacterialAnimalsMiceHumansBiofilmsDisease Models, AnimalMicrobial Sensitivity Tests

Stichwörter der Autor:innen

Helicobacter pyloricarnosic acidmode of actionnarrow‐spectrum activity

Substanzen

AbietanessalvinAnti-Bacterial Agents

Autor:innen und Institutionen

  • NHC Key Laboratory of Tropical Disease Control, School of Life Sciences and Medical Technology, Hainan Medical University, Haikou, Hainan, China.
  • Helicobacter Pylori Research Center, Department of Pathogen Biology, Jiangsu Key Laboratory of Pathogen Biology, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Institute of Dermatology, Hospital for Skin Diseases, Chinese Academy of Medical Sciences & Peking Union Medical College, Nanjing, Jiangsu, China.
  • Laboratory of Pathogen Biology, State Key Laboratory of Cardiology and Research Center for Translational Medicine, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, China.
  • Key Laboratory of Pathogen-Host Interaction, School of Medicine, Tongji University, Shanghai, China.

ORCID-Profile: Yuefan Bai, Jingchen Xu, Hongkai Bi

Förderung

  • National Natural Science Foundation of China
  • Postdoctoral Fellowship Program of the China Postdoctoral Science Foundation
  • China Postdoctoral Science Foundation
  • Hainan Provincial Natural Science Foundation of China
  • National Health Commission Key Laboratory of Tropical Disease Control of China
  • Academic Improvement Support Program of Hainan Medical University of China

Zitieren

APA

Bai, Y., Huang, H., Hang, X., Hu, S., Tong, Q., Xu, J., Jia, J., & Bi, H. (2026). Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity. Advanced Science. https://doi.org/10.1002/advs.76080

Vancouver

Bai Y, Huang H, Hang X, Hu S, Tong Q, Xu J, et al. Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity. Advanced Science. 2026. doi:10.1002/advs.76080

BibTeX
@article{Bai2026,
  author = {Bai, Yuefan and Huang, Hongming and Hang, Xudong and Hu, Shanwei and Tong, Qian and Xu, Jingchen and Jia, Jia and Bi, Hongkai},
  title = {Multi‐Targeting Carnosic Acid Kills Drug‐Resistant Helicobacter pylori With Narrow‐Spectrum Activity},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76080}
}
Kostenlos starten →